SEC Form 3 · accession 0001718871-17-000001
Oncolix, Inc. · ONCX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Health Sciences Center LLC
10% Owner
Period of report
Sep 21, 2017
Accepted (ET)
Oct 5, 2017 · 10:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001584137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 48,000,000 | D | ||
| Series A Preferred StockF1 | holding | — | — | — | 19,938,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to acquire Series A PreferredF1 | $0.0825 | holding | — | — | — | Sep 21, 2017 | Jan 16, 2020 | Series A Preferred Stock | 19,938,500 | — | D |
Explanation of responses
- F1Filer received these securities pursuant to an Assignment and Assumption Agreement dated as of September 21, 2017 between Filer and Greenville Health Research Development Corporation (GHRDC) in which Filer received all the assets and obligations of GHRDC upon the liquidation of GHRDC.